Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Amortization of Deferred Charges: 2013-2015

Historic Amortization of Deferred Charges for Enanta Pharmaceuticals (ENTA) over the last 2 years, with Jun 2015 value amounting to $2,000.

  • Enanta Pharmaceuticals' Amortization of Deferred Charges fell 60.00% to $2,000 in Q2 2015 from the same period last year, while for Mar 2015 it was $3,000, marking a year-over-year decrease of 87.50%. This contributed to the annual value of $8,000 for FY2014, which is 74.19% down from last year.
  • According to the latest figures from Q2 2015, Enanta Pharmaceuticals' Amortization of Deferred Charges is $2,000, which was down 0.00% from $2,000 recorded in Q1 2015.
  • In the past 5 years, Enanta Pharmaceuticals' Amortization of Deferred Charges ranged from a high of $8,000 in Q3 2013 and a low of -$6,000 during Q3 2014.
  • In the last 3 years, Enanta Pharmaceuticals' Amortization of Deferred Charges had a median value of $4,000 in 2014 and averaged $3,222.
  • Data for Enanta Pharmaceuticals' Amortization of Deferred Charges shows a maximum YoY crashed of 175.00% (in 2014) over the last 5 years.
  • Enanta Pharmaceuticals' Amortization of Deferred Charges (Quarterly) stood at $5,000 in 2013, then crashed by 60.00% to $2,000 in 2014, then tumbled by 60.00% to $2,000 in 2015.
  • Its Amortization of Deferred Charges was $2,000 in Q2 2015, compared to $2,000 in Q1 2015 and $2,000 in Q4 2014.